Reksa dana tingkatkan kepemilikan saham farmasi dan NBFC pada April

Manajer investasi di India mengarahkan investasi baru ke perusahaan farmasi dan lembaga keuangan bukan bank (NBFC) selama bulan April. Langkah ini menyasar saham-saham defensif di tengah kekhawatiran mengenai harga minyak dan ketegangan di Asia Barat.

Perusahaan farmasi menarik perhatian khusus karena adanya peluang seperti berakhirnya masa paten semaglutide. Saham-saham termasuk Aurobindo Pharma, Sun Pharma, Torrent Pharma, dan Mankind Pharma menjadi target aktivitas pembelian oleh skema ekuitas.

Artikel Terkait

Split-scene illustration of BSE trading floor showing high-priced stocks' divergent FY26 performance: laggards crashing amid global tensions, gainers surging.
Gambar dihasilkan oleh AI

High-priced BSE stocks diverge in FY26 performance

Dilaporkan oleh AI Gambar dihasilkan oleh AI

Among 68 high-priced stocks trading above Rs 5,000 on the BSE, FY26 has brought more declines than gains amid global uncertainty and geopolitical tensions. The top six laggards fell 25-40%, while top gainers surged 40-130%. Institutional holdings vary across these stocks.

India's small-cap stocks surged 17.1% in April, marking their best monthly performance in at least a decade. The Nifty Smallcap 250 index rebounded sharply after a steep sell-off in March. Local investors snapped up undervalued stocks with strong growth potential.

Dilaporkan oleh AI

Retail investors put ₹38,440 crore into equity mutual funds last month, a modest decline from March levels. The dip occurred amid uncertainty over oil prices and lower SIP collections.

Several brokerages have identified 10 largecap stocks in India with significant upside potential despite rising oil prices from the US-Iran war. Crude oil has surpassed $125 per barrel, fueling inflation fears and market uncertainty. Stocks like HDFC Bank and Bharti Airtel top the lists from firms including Jefferies and Axis Direct.

Dilaporkan oleh AI

Nine BSE smallcap companies delivered standout performances in the March 2026 quarter, with net profits surging over 50% year-on-year and share prices rising 50% to 170% in the past year. Four of these stocks became multibaggers, more than doubling investor returns. Data from ACE Equity highlights the momentum amid mixed results from 168 reporting firms.

Equity mutual fund inflows in India surged 56% to Rs 40,450 crore in March from Rs 25,977 crore in February, according to AMFI data. Flexi-cap funds led with a record Rs 10,054 crore, while nine categories overall saw positive inflows. Small-cap and mid-cap funds also posted strong gains amid market corrections.

Dilaporkan oleh AI

Indian IT stocks experienced a brief rebound on Wednesday, halting a five-day losing streak. Analysts, however, caution that this uptick may not last, with persistent bearish sentiments in derivatives. The sector has been under pressure in February amid growing concerns over AI's impact on revenues.

 

 

 

Situs web ini menggunakan cookie

Kami menggunakan cookie untuk analisis guna meningkatkan situs kami. Baca kebijakan privasi kami untuk informasi lebih lanjut.
Tolak